Néoplasie

Fr | De

Feedback | Impressum | Sitemap

Aucun choix d'articles!

Panier

Vous êtes ici: Recherche de documentation spécialisée » Œsophage » Néoplasie

04. Août 2026

Dépistage / diagnostic

Recherche de documentation spécialisée

Troubles de la motilité

Écriture:

Page 1 de 1971


	Articles 1 - 20 / 39416

	Bridging the gap: modern pharyngolaryngoesophagectomy techniques and the rise of neoadjuvant/immunotherapy approaches. World J Surg Oncol Nteka F, Triantafyllou T, Rouvelas I, Gkoutziotis I, Sakarellos P, Tolia M, Karavokyros I, Mpallas K, Schizas D. PMID: 42547869 [PubMed - indexed for MEDLINE]
	Winning the battle against Barrett esophagus and esophageal adenocarcinoma. Cleve Clin J Med Katzka DA. PMID: 42547280 [PubMed - indexed for MEDLINE]
	Development of an Esophageal Cancer-specific Nutrition Impact Symptom Scale for Individualized Postoperative Nutritional Nursing. J Vis Exp Cai S, Fu W. PMID: 42545907 [PubMed - indexed for MEDLINE]
	A single-arm phase III trial evaluating the non-inferiority of less-intensive surveillance for early gastric cancer: JCOG2504 (less-surveillance EGC). Jpn J Clin Oncol Kawabata K, Hayashi T, Makuuchi R, Yamada T, Yokoyama M, Uozumi T, Mitome N, Fukuda H, Kurokawa Y, Boku N, Yoshikawa T. PMID: 42545799 [PubMed - as supplied by publisher]
	ASO Visual Abstract: Neoadjuvant Chemoimmunotherapy Versus Chemoradiotherapy in Resectable Locally Advanced Esophageal Squamous Cell Carcinoma: A Systematic Review and Reconstructed Individual Patient Data Meta-Analysis. Ann Surg Oncol Xu Y, Liang Y, Gao W, Yang X, Qin F, Tao Z, Li X, Chen K, Liang Y. PMID: 42545420 [PubMed - as supplied by publisher]
	Oligometastatic esophageal squamous cell carcinoma: a systematic review of current definitions and meta-analysis of local therapy outcomes. Dis Esophagus Nomura M, Bronzwaer SFC, Kroese TE, van Rossum PSN, Ruurda JP, van Hillegersberg R, Kato K, Ogata T, Kanda M, Hamai Y, Tsubosa Y, Yoshii T, Furuta M, Sakanaka K, Matsuda S, Tsushima T, Laarhoven HWM, Takeuchi H. PMID: 42544486 [PubMed - indexed for MEDLINE]
	Tumor-microenvironment-mediated immune escape drives trastuzumab resistance in HER2-positive gastric cancer. Gastroenterol Rep (Oxf) Lv H, Zhao W, Wang SQ, He Y, Nie C, Chen XB. PMID: 42542713 [PubMed]
	Correction: Four-year follow-up from the phase 2 study TD-NICE: neoadjuvant treatment of tislelizumab combined with chemotherapy in resectable esophageal squamous cell carcinoma. BMC Cancer Mao Y, Gao Z, Sun Y, Shao C, Duan H, Yan X. PMID: 42542548 [PubMed - in process]
	Associations of PD-L1 expression status, tumor histology and patient ethnic background with immunotherapy outcomes in patients with advanced esophageal cancer. Front Pharmacol Cai X, Xie J, Zhao B. PMID: 42539557 [PubMed]
	Biomarker-Driven Initial Systemic Therapy Enabling Curative-Intent Treatment in Non-Metastatic Unresectable Salivary Duct Carcinoma: A Multi-Institutional Retrospective Study. Head Neck Kano S, Kawakita D, Honma Y, Takahashi H, Hanazawa T, Tsukahara K, Fujii S, Okami K, Yamazaki K, Ueki Y, Saito Y, Ozawa H, Imaizumi S, Arai T, Iwaki S, Hanyu K, Yamauchi M, Tanaka R, Yamamura K, Sekimizu M, Fushimi C, Matsuki T, Utsumi Y, Nakaguro M, Nagao T, Tada Y, Multi. PMID: 42538489 [PubMed - as supplied by publisher]
	A phase II randomized trial comparing radiation doses in concurrent chemoradiotherapy with TS-1/nedaplatin for curative treatment of newly diagnosed or recurrent esophageal cancer. Int J Radiat Oncol Biol Phys Yamashita H, Sawayanagi S, Kono M, Kiritoshi T, Morishima K, Jinnouchi H, Nozawa Y, Katano A. PMID: 42537853 [PubMed - as supplied by publisher]
	Robotic Versus Laparoscopic Gastrectomy for Advanced Gastric Cancer: Prognostic Implications of Surgical Recovery and Oncologic Control in a Propensity Score-Matched Study. Ann Surg Oncol Komatsu S, Konishi T, Ohashi T, Nagamori H, Ogawa S, Matsumoto Y, Fujita Y, Matsuo H, Kuriu Y, Ikoma H, Okamoto K, Otsuji E, Shiozaki A. PMID: 42536238 [PubMed - as supplied by publisher]
	Zolbetuximab in the treatment of advanced gastric and gastroesophageal junction cancer: a systematic review. Front Immunol Picheta N, Piekarz J, Pobide, Szklener K, Skórzewska M. PMID: 42534935 [PubMed - indexed for MEDLINE]
	Evaluating the effect of cigarettes smoking on oesophageal cancer risk: a systematic review and meta-analysis with dose-response relationships. Eur J Public Health Teshima A, Possenti I, Bertacchi D, Bagnardi V, Specchia C, Martinez C, Fernández E, Gallus S, Lugo A. PMID: 42533755 [PubMed - indexed for MEDLINE]
	The Prognostic Impact of Lymph Node Yield Upon Survival in Esophageal Cancer Broken Down by Neoadjuvant Strategy: A Multicenter European Cohort Study. Ann Surg Guidozzi N, Chou WK, Giorgi L, Salem R, Vanstraelen S, Gielen H, Moons J, Nafteux P, Lammes FE, Ruurda JP, van Hillegersberg R, Todesco A, D'Journo XB, Collizzolli A, Ajazi B, Giacopuzzi S, Bencivenga M, Alhayo S, Seabourne E, Griffiths EA, Abu Hejleh A, Schiffmann LM, Bruns CJ, Garbarino GM, Pansa A, Basato S, Bacoeur-Ouzillou O, Gronnier C, Henckens SPG, Gisbertz SS, Ahmed R, Loganathan N, Elliott JA, Cole K, Ibrahim Y, Anand C, Pucher PH, Skogar M, Hedberg J, Bonnin E, Veziant J, Piessen G, Carresi A, Battaglia S, Puccetti F, Rosati R, Murad F, Klevebro F, Nilsson M, Nieuwenhuijzen GAP, van de Sanden L, Luyer MDP, Alfieri R, Castoro C, van Berge Henegouwen MI, Markar SR. PMID: 42533309 [PubMed - as supplied by publisher]
	An integrated individual patient-level database from JCOG trials in esophageal cancer: A research platform (JCOG2512A). Eur J Surg Oncol Kawabata K, Matsuda S, Tsushima T, Ishiyama K, Ishikawa Y, Machida R, Uozumi T, Sasaki K, Fukuda H, Kato K, Daiko H, Takeuchi H, Japan Esophageal Oncology Group in the Japan Clinical Oncology Group. PMID: 42531880 [PubMed - as supplied by publisher]
	Oligoprogression in Advanced Gastric and Gastroesophageal Junction Cancer: Integrating Local Therapy, Systemic Treatment Continuation, and Biomarker Reassessment. J Gastrointest Cancer Sagawa T, Hirakawa M, Nagashima H, Fujikawa K. PMID: 42530766 [PubMed - indexed for MEDLINE]
	Corrigendum to 'A Phase 1b Clinical Trial of Neoadjuvant Radio-immunotherapy for Esophageal Squamous Cell Cancer '[International Journal of Radiation OncologyBiologyPhysics Volume 119, Issue 3, 1 July 2024, Pages 896-901]. Int J Radiat Oncol Biol Phys Li M, Sun H, Yang W, Luo J, Lin H, Zhou T, Gong H, Zhao D, Niu Z, Wang Z, Liu B, Yi Y, Huang W, Li B. PMID: 42530499 [PubMed - as supplied by publisher]
	Survival Outcomes of Adjuvant Nivolumab after Neoadjuvant Chemotherapy in Esophageal Squamous Cell Carcinoma. Ann Thorac Cardiovasc Surg Zeng R, Mine S, Nasu M, Hashimoto T, Makuuchi R, Ozaki A, Yoshimoto Y, Watanabe T, Takai S, Fukunaga T. PMID: 42528212 [PubMed - indexed for MEDLINE]
	Dedicated Endoscopy for Barrett's Oesophagus With Higher Dysplasia Yield May Reduce Seattle Protocol Biopsies: Results From UK Multicentre Study. United European Gastroenterol J Gamakaranage C, Britton J, Ratcliffe E, Prasad N, Keld R, Murgatroyd M, Balakrishnan S, Aslam N, Sehgal V, Marsh J, Plant D, Johnston M, Kateroglou S, Baker J, Morgan H, Cipriano C, Dhar A, Hamdy S, McLaughlin J, Ang Y, DEBO group. PMID: 42528176 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 39416

Page 1 de 1971



		Intervalle de temps demandé

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy \| Publicité